Search research articles
Contact Us
Filters
Showing results (261-270 of 2,232) with videos related to
Page
of 224
Sort By:
Current Opinion in Urology
|
June 4, 2019
Editorial: What we know, what we don't know and what we need to know
Christopher R Chapple, Sheila MacNeil
The Journal of Urology
|
November 1, 1993
The UroLume stent in the management of benign prostatic hyperplasia
E Milroy, C R Chapple
BJU International
|
August 18, 2009
The second-line management of idiopathic overactive bladder: what is the place of sacral neuromodulation and botulinum toxin-A in contemporary practice?
Christopher Chapple, Dirk De Ridder
World Journal of Urology
|
May 23, 2002
Tamsulosin: an overview
Christopher Chapple, Karl-Erik Andersson
Journal of Clinical Periodontology
|
April 27, 2012
Clinical research on peri-implant diseases: consensus report of Working Group 4
Mariano Sanz, Iain L Chapple,
Current Opinion in Urology
|
March 22, 2000
Contemporary management of urethral trauma and the post-traumatic stricture
C R Chapple, D Png
European Urology
|
June 7, 2005
Comparison of darifenacin and oxybutynin in patients with overactive bladder: assessment of ambulatory urodynamics and impact on salivary flow
C R Chapple, P Abrams
Cureus
|
July 12, 2021
Evaluation and Acceptance of an Electric Toothbrush Designed for Dependent Patients
Virginia Prendergast, Kristina M Chapple
F1000 Medicine Reports
|
December 22, 2010
Tissue engineering in urethral reconstruction
Altaf Mangera, Christopher R Chapple
British Journal of Anaesthesia
|
September 1, 1976
Cardiovascular and neuromuscular effects of dimethyl tubocurarine in anaesthetized cats and rhesus monkeys
R Hughes, D J Chapple
Page
of 224
Search research articles
Search
Showing results (261-270 of 2,232) with videos related to
Sort By:
Page
of 224
Current Opinion in Urology
|
June 4, 2019
Editorial: What we know, what we don't know and what we need to know
Christopher R Chapple, Sheila MacNeil
The Journal of Urology
|
November 1, 1993
The UroLume stent in the management of benign prostatic hyperplasia
E Milroy, C R Chapple
BJU International
|
August 18, 2009
The second-line management of idiopathic overactive bladder: what is the place of sacral neuromodulation and botulinum toxin-A in contemporary practice?
Christopher Chapple, Dirk De Ridder
World Journal of Urology
|
May 23, 2002
Tamsulosin: an overview
Christopher Chapple, Karl-Erik Andersson
Journal of Clinical Periodontology
|
April 27, 2012
Clinical research on peri-implant diseases: consensus report of Working Group 4
Mariano Sanz, Iain L Chapple,
Current Opinion in Urology
|
March 22, 2000
Contemporary management of urethral trauma and the post-traumatic stricture
C R Chapple, D Png
European Urology
|
June 7, 2005
Comparison of darifenacin and oxybutynin in patients with overactive bladder: assessment of ambulatory urodynamics and impact on salivary flow
C R Chapple, P Abrams
Cureus
|
July 12, 2021
Evaluation and Acceptance of an Electric Toothbrush Designed for Dependent Patients
Virginia Prendergast, Kristina M Chapple
F1000 Medicine Reports
|
December 22, 2010
Tissue engineering in urethral reconstruction
Altaf Mangera, Christopher R Chapple
British Journal of Anaesthesia
|
September 1, 1976
Cardiovascular and neuromuscular effects of dimethyl tubocurarine in anaesthetized cats and rhesus monkeys
R Hughes, D J Chapple
Page
of 224